GlaxoSmithKline Pharmaceuticals Limited
GLAXO
Pozycja w akcjach
#3638
GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise,... GlaxoSmithKline Pharmaceuticals Limited, an India-based healthcare enterprise, engages in the research, development, production, and global distribution of pharmaceutical drugs and vaccines. Its extensive product range encompasses both prescription and over-the-counter medications addressing diverse therapeutic areas such as anti-infectives, respiratory ailments, dermatology, nutritional deficiencies, gastrointestinal issues, and rare conditions. The company additionally provides consumer healthcare solutions. Prominent brands within its portfolio include Augmentin, Calpol, Ceftum, Eltroxin, Neosporin, Betnovate, Infanrix Hexa, Synflorix, and Boostrix, among numerous others. Founded in 1924 and headquartered in Mumbai, India, the company adopted its current name in 2001, having previously operated as SmithKline Beecham Pharmaceuticals India Ltd.
Cena akcji
$27.54
Ostatnia synchronizacja: 2026-10-19
Kapitalizacja rynkowa
$4.67B
Zmiana (1 dzień)
-2.73%
Zmiana (1 rok)
-11.86%
Kraj
IN
Handel GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Kategoria
Healthcare
Historia stopy dywidendy dla GlaxoSmithKline Pharmaceuticals Limited (GLAXO)
Stopa dywidendy (TTM) dla GlaxoSmithKline Pharmaceuticals Limited (symbol akcji: GLAXO) na dzień 2024-03-31 wynosi: 1.61%
Średnia stopa dywidendy z ostatnich 5 lat: 2.91%
Średnia stopa dywidendy z ostatnich 5 lat: 2.91%
Historia stopy dywidendy dla GlaxoSmithKline Pharmaceuticals Limited (GLAXO) od 2004 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
| Rok | Stopa dywidendy | Zmień |
|---|---|---|
| 2026 (TTM) | 2.28% | 44.30% |
| 2025 | 1.58% | -1.86% |
| 2024 | 1.61% | -76.32% |
| 2023 | 6.80% | 279.89% |
| 2022 | 1.79% | -35.38% |
| 2021 | 2.77% | 44.27% |
| 2020 | 1.92% | 42.22% |
| 2019 | 1.35% | -5.59% |
| 2018 | 1.43% | -21.43% |
| 2017 | 1.82% | 10.98% |
| 2016 | 1.64% | 40.17% |
| 2015 | 1.17% | -29.52% |
| 2013 | 1.66% | -19.42% |
| 2012 | 2.06% | 0.49% |
| 2011 | 2.05% | 60.16% |
| 2010 | 1.28% | -48.18% |
| 2009 | 2.47% | -20.58% |
| 2008 | 3.11% | 3.67% |
| 2007 | 3.00% | 25.00% |
| 2006 | 2.40% | 10.60% |
| 2005 | 2.17% | 65.65% |
| 2004 | 1.31% | 0.00% |
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
| Firma | Stopa dywidendy | Kraj |
|---|---|---|
| 0.55% |
US
|
|
| 2.08% |
US
|
|
| 2.44% |
US
|
|
| 2.31% |
US
|
|
| 2.69% |
CH
|
